FDA schedules public meetings for DSCSA

FDA is following through on requirements, under the Drug Supply Chain Security Act (DSCSA), to hold public meetings on where it is going with the law, whose implementation started in 2015 and will continue (under current timetables) until 2023. A […]

Read More

A Conversation with John Chiminski, Catalent

In April, Catalent, Inc., celebrated its 10th anniversary of its inception, having been spun out of Cardinal Health in 2007 and acquired by Blackstone Group, a private-equity firm. Later, in 2014, the company went public, traded on the NYSE. Both […]

Read More